Peripheral Nerve Destruction for Pain Conditions

Diagnostic Occipital Nerve Block Required

Before occipital radiofrequency neurotomy, perform a diagnostic block of the suspected occipital nerve and document the response. Alternative causes of the pain must be excluded.

• Confirm the greater or lesser occipital nerve as the pain generator through diagnostic blockade.
• Document exclusion of alternative etiologies before proceeding.

Cervical RFA Requires 80% Diagnostic Relief

Cervical radiofrequency ablation should be considered only after a diagnostic block produces 80% pain relief, consistent with guideline-supported patient selection.

• Document the diagnostic block result and percentage of pain relief.
• Record the cervical nerve or medial branch targeted.

Document Failure of Conservative Therapy

Reserve neuroablative procedures for patients who have not achieved adequate relief with conservative or less invasive therapies.

• Document prior conservative treatment, such as physical therapy, medications, posture exercises, massage, or other appropriate measures.
• Document failure, inadequate relief, or intolerance of less invasive interventions before neuroablation.

Identify Procedure, Nerve, and Indication

Clearly identify the procedure performed or requested, the specific nerve or nerve branch targeted, and the pain condition or indication in the clinical record and claim.

• Specify the ablation or neurolytic technique.
• Identify the treated nerve, branch, or nerve plexus.
• Link the procedure to the documented indication.

Document Headache or Occipital Neuralgia Diagnosis

For headache or occipital neuralgia, document the clinical diagnosis using history, physical examination, and appropriate imaging when indicated. A positive diagnostic nerve block supports the diagnosis.

• Describe the characteristic headache or occipital neuralgia pattern and relevant examination findings.
• Document MRI or CT findings when clinically indicated.
• Record diagnostic block response.

Diagnostic Blockade Before Occipital Neurotomy

A diagnostic occipital nerve blockade should precede occipital neurotomy, with documentation that the greater or lesser occipital nerve is the confirmed pain generator.

• Document the nerve blocked and the degree and duration of relief.
• Do not proceed without evaluating alternative pain etiologies.

Document SI Joint Pain Evaluation

For sacroiliac joint pain, document chronicity, examination findings, injection or block response, pain severity, and the absence of another major identifiable source of low back pain.

• Document at least three months of chronic SI joint pain.
• Record at least one positive provocation test.
• Document at least 50% relief from a diagnostic or therapeutic SI joint injection and lateral branch block.
• Document average NRS pain of at least 4 and evaluation for competing causes of low back pain.

Use Covered Diagnoses and Procedure Codes

Submit services with the covered diagnosis and procedure codes applicable on the date of service. Claims lacking covered codes under the policy may be denied as not covered.

• Use the most appropriate current codes as of the submission date.
• Ensure the diagnosis and procedure code combination matches the policy indication.
• Verify the applicable benefit plan document and any controlling mandate.

Excluded Pain Conditions and Indications

Peripheral nerve destruction using cryoablation, laser, electrical, chemical, or radiofrequency ablation is not covered or reimbursable for the listed pain conditions.

• Sacroiliac joint pain, knee pain, hip pain, shoulder pain, and foot or heel pain.
• Headache, occipital neuralgia, and intercostal neuralgia.
• Extremity pain due to complex regional pain syndrome, peripheral nerve entrapment or compression, or peripheral neuropathy.

Ablation Techniques Not Medically Necessary

The following ablative techniques are considered not medically necessary for pain conditions under this policy.

• Percutaneous cryoablation.
• Pulsed radiofrequency ablation.
• Peripheral nerve destruction using cryoablation, laser, electrical, chemical, or radiofrequency ablation for excluded indications.

Verify Code Validity and Effective Dates

Deleted codes and codes that are not effective on the date the service is rendered may not be eligible for reimbursement.

• Confirm code validity and effective dates before claim submission.
• Check AMA and CMS updates because code lists may change more frequently than the policy.

Avoid Excluded Diagnosis Associations

Do not associate peripheral nerve destruction claims with diagnosis codes listed as not covered or reimbursable for the policy’s pain indications.

• Review the complete applicable ICD-10-CM exclusion list, including listed shoulder, ankle, foot, and joint conditions.
• Ensure the diagnosis association reflects the actual covered indication, when applicable.

Use Listed Diagnosis Indications

Use peripheral nerve destruction only for diagnosis indications listed as covered under the applicable policy and benefit plan; listed conditions that are not covered or reimbursable will result in denial risk.

• Confirm the diagnosis is an eligible policy indication before scheduling or billing.
• Do not rely on a procedure code alone to establish coverage.

Document Procedure-Related Risks

Neuroablative procedures can cause clinically significant complications, and these risks should be considered and documented during informed consent and treatment planning.

• Bleeding, infection, prolonged numbness or tingling, temporary increased pain, and injury to nearby tissue.
• Cryoanalgesia may cause skin color changes or frostbite-type injury.
• Chemical neurolysis may cause neuritis, neuraxial spread, or unintended tissue destruction.

Headache or Occipital Neuralgia: Insufficient Evidence

Evidence is insufficient to demonstrate the safety and efficacy of peripheral nerve ablation for cervicogenic headache or occipital neuralgia.

• Coverage or reimbursement remains at risk despite reported short-term benefits.
• Document clinical rationale, alternatives, and the limited and conflicting evidence when requesting the service.

Intercostal Neuralgia: Insufficient Evidence

Evidence is insufficient to demonstrate the safety and efficacy of peripheral nerve ablation for intercostal neuralgia.

• Do not assume coverage based on guideline discussion or an individual diagnostic response.
• Document alternatives and the rationale if the procedure is considered.

Shoulder Pain: Insufficient Evidence

Evidence is insufficient to demonstrate the safety and efficacy of peripheral nerve ablation for shoulder pain.

• Shoulder pain is also identified as an excluded pain condition under the policy.
• Expect coverage and reimbursement risk for ablation performed for this indication.

SI and Lumbar-Related Pain: Insufficient Evidence

Evidence is insufficient to establish the safety and efficacy of SI joint radiofrequency ablation, lumbar or sacral dorsal ramus ablation, or other ablative modalities for SI joint and related lumbar pain.

• Applicable modalities include radiofrequency, laser, chemical, and electrical ablation.
• A weak guideline recommendation does not establish sufficient evidence for coverage.

Hip Pain: Insufficient Evidence

Evidence is insufficient to demonstrate the safety and effectiveness of peripheral nerve ablation for hip pain, regardless of the ablation method.

• Although diagnostic-block-selected hip RFN has been studied, evidence remains limited and substantial gaps persist.
• Expect coverage and reimbursement risk for hip pain ablation.

Knee Osteoarthritis: Limited Evidence

Current evidence does not support routine use of radiofrequency ablation or related minimally invasive interventions for knee osteoarthritis.

• Evidence is limited by small or methodologically constrained studies and short follow-up.
• Knee pain is an excluded pain condition under the policy.

Peripheral Neuroma Ablation Is Investigational

Neuroablative treatment for peripheral neuroma, including Morton’s neuroma, lacks sufficient evidence and should be considered investigational or a research treatment until further study is available.

• Alcohol injections and radiofrequency ablation have only shown promise in observational case series.
• Document that evidence is insufficient to establish safety and efficacy.

Foot Pain Ablation: Insufficient Evidence

Evidence is insufficient to demonstrate the safety and effectiveness of peripheral nerve ablation for foot pain.

• Ablation as primary treatment of Morton’s neuroma is not recommended in the cited guideline.
• Foot and heel pain are excluded pain conditions under the policy.

Other Pain Conditions: Insufficient Evidence

The policy identifies insufficient evidence for peripheral nerve destruction in other pain conditions, including complex regional pain syndrome, chronic thoracic pain, craniofacial pain, pudendal neuralgia, nerve compression or entrapment, peripheral neuropathy, post-amputation pain, post-herniorrhaphy pain, and oncologic pain.

• Do not represent these procedures as established effective treatment for these conditions.
• Document the limited evidence and consider established alternatives.

Insufficient Evidence for Other Pain Conditions

There is a paucity of peer-reviewed evidence supporting the safety and efficacy of neuroablative procedures for pain conditions outside the specifically evaluated indications.

• This includes chronic regional pain syndrome, chronic thoracic pain, craniofacial pain syndromes, pudendal neuralgia, peripheral nerve compression or entrapment, peripheral neuropathic conditions, post-amputation pain, post-inguinal herniorrhaphy pain, and oncologic pain.
• Treat such uses as unsupported unless applicable plan terms or updated evidence establish coverage.

Follow imaging requirements embedded in code descriptions

Check the procedure code description for embedded imaging requirements. Listed percutaneous cryoablation codes and selected neurolytic nerve destruction codes include imaging guidance in the code description; the policy does not establish a separate general imaging requirement.

Use appropriate diagnostic evaluation

For evaluation of suspected cervicogenic headache or occipital neuralgia, use clinical criteria, history, and physical examination; MRI or CT may be used as part of the diagnostic evaluation, and relief after a diagnostic nerve block supports the diagnosis.